Climb Bio, Inc.
5 private offerings reported to the SEC on Form D since 2016, $201.4M sold in all. Biotech, MA.
- Form D offerings: 5
- Reported sold: $201.4M
- Newest: May 4, 2026
Every Form D Offering
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.| May 4, 2026 | $110.1M | $110.1M | Climb Bio, Inc.Biotech · MA | Not amended | 0001768446-26-000001 |
| May 28, 2021 | $60.0M | $60.0M | Eliem Therapeutics, Inc.Pharma · WA | Not amended | 0001768446-21-000001 |
| Nov 3, 2020 | $5.0M | $50.0M | Eliem Therapeutics, Inc.Pharma · WA | Not amended | 0001768446-20-000003 |
| Oct 23, 2019 | $10.0M | $10.0M | Eliem Therapeutics, Inc.Pharma · MA | Not amended | 0001768446-19-000003 |
| Feb 19, 2019 | $16.3M | $16.3M | Eliem Therapeutics, Inc.Pharma · MA | Oct 23, 2019 | 0001567619-19-004873 |
SEC Profile
From the company's EDGAR record- Ticker
- CLYM
- Business address
- Wellesley Hills, Ma
- Incorporated in
- DE
- SEC industry
- Pharmaceutical Preparations
- Former names
- Eliem Therapeutics, Inc.
- All SEC filings
- CIK 1768446 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR